{"title":"HHS announces elimination of SAMHSA","authors":"","doi":"10.1002/cpu.30970","DOIUrl":"https://doi.org/10.1002/cpu.30970","url":null,"abstract":"","PeriodicalId":22496,"journal":{"name":"The Brown University Child & Adolescent Psychopharmacology Update","volume":"27 5","pages":"7"},"PeriodicalIF":0.0,"publicationDate":"2025-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143818515","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Prescription stimulant prescribing, nonmedical use, and shortages: US FDA research and response","authors":"","doi":"10.1002/cpu.30971","DOIUrl":"https://doi.org/10.1002/cpu.30971","url":null,"abstract":"<p>Shortages of prescription stimulant medications have been a challenge for patients with attention-deficit/hyperactivity disorder (ADHD) and other conditions since they began in October 2022. The US Food and Drug Administration (FDA) is committed to understanding and addressing these shortages, which are occurring in the context of significant growth in the dispensing of prescription stimulant medications to adults. Prescription stimulants are Schedule II controlled substances, defined as drugs with “high potential for abuse that may lead to severe psychological or physical dependence.” Questions remain about what is driving increased prescribing of these medications and their potential for misuse; the 2023 National Survey on Drug Use and Health estimated that 3.9 million persons aged 12 years and older in the United States used prescription stimulants nonmedically in the past year. Because the production of Schedule II substances is limited by the Drug Enforcement Administration (DEA), the usual dynamics of supply and demand in the medication marketplace do not apply.</p>","PeriodicalId":22496,"journal":{"name":"The Brown University Child & Adolescent Psychopharmacology Update","volume":"27 5","pages":"7-8"},"PeriodicalIF":0.0,"publicationDate":"2025-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143818635","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"APA finds many daily online gamblers started as 18–25 year olds","authors":"Alison Knopf","doi":"10.1002/cpu.30966","DOIUrl":"https://doi.org/10.1002/cpu.30966","url":null,"abstract":"","PeriodicalId":22496,"journal":{"name":"The Brown University Child & Adolescent Psychopharmacology Update","volume":"27 5","pages":"5-6"},"PeriodicalIF":0.0,"publicationDate":"2025-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143818486","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Functional connectivity and the developing brain: Researchers present data at CNS","authors":"Alison Knopf","doi":"10.1002/cpu.30967","DOIUrl":"https://doi.org/10.1002/cpu.30967","url":null,"abstract":"","PeriodicalId":22496,"journal":{"name":"The Brown University Child & Adolescent Psychopharmacology Update","volume":"27 5","pages":"6"},"PeriodicalIF":0.0,"publicationDate":"2025-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143818487","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Smart watch can help sleep","authors":"Alison Knopf","doi":"10.1002/cpu.30968","DOIUrl":"https://doi.org/10.1002/cpu.30968","url":null,"abstract":"","PeriodicalId":22496,"journal":{"name":"The Brown University Child & Adolescent Psychopharmacology Update","volume":"27 5","pages":"6"},"PeriodicalIF":0.0,"publicationDate":"2025-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143818495","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Clinical practice guideline on benzodiazepine tapering available from ASAM","authors":"","doi":"10.1002/cpu.30965","DOIUrl":"https://doi.org/10.1002/cpu.30965","url":null,"abstract":"","PeriodicalId":22496,"journal":{"name":"The Brown University Child & Adolescent Psychopharmacology Update","volume":"27 5","pages":"5"},"PeriodicalIF":0.0,"publicationDate":"2025-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143818638","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Three new studies highlight risks of cannabis use","authors":"Alison Knopf","doi":"10.1002/cpu.30961","DOIUrl":"https://doi.org/10.1002/cpu.30961","url":null,"abstract":"<p>Added to the many studies in the literature detailing the risks of cannabis use, particularly early onset psychosis in young people, one new report highlights clear risks to human offspring of cannabis-using mothers. In utero exposure to cannabis resulted in three times the risk of the child developing behavioral problems, according to the study.</p>","PeriodicalId":22496,"journal":{"name":"The Brown University Child & Adolescent Psychopharmacology Update","volume":"27 5","pages":"1-3"},"PeriodicalIF":0.0,"publicationDate":"2025-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143818380","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Industry considers concerns about blinding in trials with psychedelics","authors":"Alison Knopf","doi":"10.1002/cpu.30962","DOIUrl":"https://doi.org/10.1002/cpu.30962","url":null,"abstract":"<p>Not for the first time, experts have expressed concern about whether randomized controlled trials (RCTs) can be conducted with psychedelics. A placebo for a drug with such a powerful effect would be difficult to create. But placebos are needed to prove that a medication works because it works, not because the patient thinks it will (the so-called “placebo effect”). To avoid the placebo effect misguiding results, participants are “blinded” as to whether they are taking the placebo or the study drug. (In “double-blind” studies, the researchers don't know, either.)</p>","PeriodicalId":22496,"journal":{"name":"The Brown University Child & Adolescent Psychopharmacology Update","volume":"27 5","pages":"1-3"},"PeriodicalIF":0.0,"publicationDate":"2025-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143818778","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Medical groups issue joint statement on psychotropic safety","authors":"Alison Knopf","doi":"10.1002/cpu.30964","DOIUrl":"https://doi.org/10.1002/cpu.30964","url":null,"abstract":"<p>In its “Joint Statement on Federal Concerns About Psychotropic Medication Safety March 21, 2025,” medical organizations stated.</p>","PeriodicalId":22496,"journal":{"name":"The Brown University Child & Adolescent Psychopharmacology Update","volume":"27 5","pages":"4-5"},"PeriodicalIF":0.0,"publicationDate":"2025-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143818637","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}